237 related articles for article (PubMed ID: 23551679)
21. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
Wald R; Tentori F; Tighiouart H; Zager PG; Miskulin DC
Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
[TBL] [Abstract][Full Text] [Related]
22. Associations among time-average mineral values, mortality and cardiovascular events in hemodialysis patients.
Wu HC; Lee LC; Wang WJ
Ren Fail; 2015 Nov; 37(10):343-53. PubMed ID: 26375759
[TBL] [Abstract][Full Text] [Related]
23. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
Fernández-Martín JL; Martínez-Camblor P; Dionisi MP; Floege J; Ketteler M; London G; Locatelli F; Gorriz JL; Rutkowski B; Ferreira A; Bos WJ; Covic A; Rodríguez-García M; Sánchez JE; Rodríguez-Puyol D; Cannata-Andia JB;
Nephrol Dial Transplant; 2015 Sep; 30(9):1542-51. PubMed ID: 25920921
[TBL] [Abstract][Full Text] [Related]
24. Adherence to mineral and bone disorder clinical practice guidelines in chronic kidney disease.
Panawong W; Chaiyakum A; Pongskul C
J Med Assoc Thai; 2011 Oct; 94(10):1175-83. PubMed ID: 22145501
[TBL] [Abstract][Full Text] [Related]
25. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
Maduell F; Gorriz JL; Pallardo LM; Pons R; Santiago C;
J Nephrol; 2005; 18(6):739-48. PubMed ID: 16358233
[TBL] [Abstract][Full Text] [Related]
26. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
[TBL] [Abstract][Full Text] [Related]
27. Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Noordzij M; Korevaar JC; Dekker FW; Boeschoten EW; Bos WJ; Krediet RT; Bossuyt PM; Geskus RB;
Blood Purif; 2008; 26(3):231-7. PubMed ID: 18305386
[TBL] [Abstract][Full Text] [Related]
28. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
[TBL] [Abstract][Full Text] [Related]
29. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
Wazny LD; Raymond CB; Lesperance EM; Bernstein KN
CANNT J; 2008; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
[TBL] [Abstract][Full Text] [Related]
30. K/DOQI guideline requirements for calcium, phosphate, calcium phosphate product, and parathyroid hormone control in dialysis patients: can we achieve them?
Wei M; Taskapan H; Esbaei K; Jassal SV; Bargman JM; Oreopoulos DG
Int Urol Nephrol; 2006; 38(3-4):739-43. PubMed ID: 17160632
[TBL] [Abstract][Full Text] [Related]
31. Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery.
Yan H; Sharma J; Weber CJ; Guyton RA; Perez S; Thourani VH
Surgery; 2011 Dec; 150(6):1095-101. PubMed ID: 22136827
[TBL] [Abstract][Full Text] [Related]
32. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
33. VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey.
Cozzolino M; Brancaccio D; Cannella G; Messa P; Gesualdo L; Marangella M; LoDeserto C; Pozzato M; Rombolà G; Costanzo AM; di Luzio Paparatti U; Mazzaferro S;
Nephrol Dial Transplant; 2012 Sep; 27(9):3588-94. PubMed ID: 22523119
[TBL] [Abstract][Full Text] [Related]
34. Can calcium, phosphate, calcium phosphate product and intact parathyroid hormone levels be appropriately controlled in dialysis patients?
Deger SM; Mutluay R; Derici U; Mandiralioglu F; Arinsoy T; Sindel S
Med Princ Pract; 2011; 20(1):85-9. PubMed ID: 21160221
[TBL] [Abstract][Full Text] [Related]
35. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
Rubel JR; Milford EL
Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
[TBL] [Abstract][Full Text] [Related]
37. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
Kanbay M; Isik B; Akcay A; Ozkara A; Karakurt F; Turgut F; Alkan R; Uz E; Bavbek N; Yigitoglu R; Covic A
Am J Nephrol; 2007; 27(5):516-21. PubMed ID: 17703091
[TBL] [Abstract][Full Text] [Related]
38. The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan.
Yokoyama K; Katoh N; Kasai K; Kubo H; Murai S; Shoji R; Imamura N; Saika S; Yumita S; Ishida M; Takasu S; Kono T; Yoshida Y; Wakabayashi T; Kimua Y; Hosoya T
Ther Apher Dial; 2006 Jun; 10(3):257-61. PubMed ID: 16817790
[TBL] [Abstract][Full Text] [Related]
39. [CA-P control in haemodialysis and K/DOQI guidelines].
Rivera F; Sánchez de la Nieta MD; Echarri R; Anaya S; Carreño A; Vozmediano MC; Alcaide MP
Nefrologia; 2006; 26(3):351-7. PubMed ID: 16892824
[TBL] [Abstract][Full Text] [Related]
40. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
Arenas MD; Alvarez-Ude F; Gil MT; Moledous A; Malek T; Nuñez C; Devesa R; Carretón MA; Soriano A
Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
